Related Experiment Video
Updated: May 4, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Valvular manifestations of human immunodeficiency virus infection--results from the prospective, multicenter
Nico Reinsch1, Stefan Esser, Götz Gelbrich
1aDepartment of Cardiology, West-German Heart Center bDepartment of Dermatology and Venereology, University of Essen, Essen cCenter for Clinical Trials (ZKS), University of Leipzig, Leipzig dDepartment of Dermatology, Ruhr-University Bochum, Bochum, Germany.
Insights
Valvular heart disease is common in HIV patients, with most cases being mild. However, advanced HIV infection stages correlate with a higher prevalence of these cardiac conditions.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- HIV infection is linked to increased cardiac disease risk.
- Valvular disorders are a significant concern in this population.
Purpose of the Study:
- To determine the prevalence of valvular heart disorders in a large cohort of HIV-infected individuals.
- To explore associations between valvular disorders and HIV disease severity.
Main Methods:
- Prospective, multicenter cohort study of 803 HIV-infected adults.
- Comprehensive two-dimensional transthoracic echocardiography with Doppler evaluation.
- Statistical analysis stratified by HIV infection severity.
Main Results:
- 77.6% of patients exhibited pathological valve function, primarily regurgitation (77.2%).
- Clinically significant valvular disorders were found in 4.7% of patients.
- Higher rates of valvular disease were associated with advanced HIV stages (CDC B/C vs. A).
Conclusions:
- Valvular heart diseases are prevalent in HIV-infected patients.
- Most valvular disorders in this cohort were mild.
- Clinical stage of HIV infection is associated with the development of valvular heart disease.
Background And Aims:
HIV infection is associated with an elevated rate of cardiac diseases. The aim of the current study was to assess the prevalence of valvular disorders in a large population of HIV-infected patients.
Methods:
We enrolled 803 adults (age 44 ± 10 years, 16.6% women) in this prospective, multicenter cohort study. All patients underwent a comprehensive two-dimensional transthoracic echocardiography examination including Doppler evaluation of valvular function. Statistical analyses were performed in respect of severity of HIV infection.
Results:
Overall, the rate of patients with pathologic function of cardiac valves was 77.6% (N = 623). Most of these patients had signs of valvular regurgitation (N = 620; 77.2%), whereas stenoses were rare (N = 23; 2.9%). Clinically relevant valvular disorders (excluding mild stages) were seen in only 4.7% (N = 38; regurgitation: N = 36, 4.5%; stenosis: N = 3, 0.4%). Clinical stages of HIV infection, defined by the Centers for Disease Control and Prevention (CDC) classification, were associated with higher rates of valvular diseases (CDC-stage B/C versus A: 6.2 versus 2.3%, P = 0.015). However, there was no association between current CD4 cell count or virus load and the prevalence of valvular disorders (both P > 0.2). None of the patients had signs of active endocarditis in the present study.
Conclusion:
Valvular heart diseases are common in HIV-infected patients. Fortunately, most of these disorders are mild today. We found an association between the onset of valvular heart disease and clinical stages of HIV infection.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Heart Failure III: Clinical Manifestations
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Sexually Transmitted Infections

